Clinical Trial Update: Curcuminoids for the Treatment of Chronic Psoriasis Vulgaris [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluates curcuminoids for chronic psoriasis vulgaris and has completed; the sponsor is the University of Pennsylvania.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Curcuminoids (curcuminoids)

Snippet

Sponsor: University of Pennsylvania | Conditions: Psoriasis | Phase 2 | Status: COMPLETED